← SynDRA
SKF-38393
SynDRA canonical compound SYN0001912 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | DRD5 |
| Mechanism of action | Dopamine receptor agonist |
All known targets
Mechanisms of action (all sources)
- Dopamine receptor agonist
- DRD1 PARTIAL AGONIST
- DRD5 PARTIAL AGONIST
- DRD1 MODULATOR
Drug classes
Cross-references
Synonyms
- NCG-C00093856-01
- SK&F-383933
- SK-383933
- F 38393
- SKF38393
- BRN 1543419
- CHEMBL286080
- 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol
- 2,3,4,5-Tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol
- 1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
- SKF-38,393
- SK-38393
- C16H17NO2
- 5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
- 1-Phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol
- Skf 38393
- SK&F 38393
- R7TF327S2C
- SKF 38393 A
- RSK&F 38393
- SK&F38393
- RefChem:388746
- CHEBI:131793
- SKF-38393, (A+-)-
- SKF-38393 free base
- 6-PHENYL-4-AZOBICYCLO[5.4.0]UNDECA-7,9,11-TRIENE-9,10-DIOL
- Biomol-NT_000034
- UNII-R7TF327S2C
- Lopac0_000436
- BSPBio_002384
- GTPL935
- 5-21-05-00258 (Beilstein Handbook Reference)
- SCHEMBL469578
- SPECTRUM1505101
- BPBio1_001229
- cid_147514
- SCHEMBL29389401
- CHEBI:110200
Look up SKF-38393 in the interactive SynDRA portal →